Talde Private Equity becames a shareholder of Patia
28 February 2022
ARCANO acts as exclusive Financial Advisor to Patia and its shareholders in the capital increase process subscribed by Talde.
Chemicals & Pharma
June 30 2020
Development of diagnostic tests
Patia, dedicated to Public Health, integrates genetic, metabolomic and digital tools to facilitate the prevention of Type 2 diabetes and gestational diabetes.
Patia has its own technology developed in collaboration with some of the most prestigious research centers in Europe and America.
Talde Group is venture capital firm headquartered in Bilbao -Spain- focused on Spanish small and medium companies and support their plans to grow.